Wolverine Trading, LLC Bluebird Bio, Inc. Call Options Transaction History

Wolverine Trading, LLC

$93.9 Billion
Q3 2024

Call Options

25 transactions

Quarter	Operation	Price Per call	calls change	calls Held
Q3 2024 Nov 14, 2024	BUY	$0.47 - $1.35 $893 - $2,565	1,900 Added 7.14%	28,500 $14,000
Q2 2024 Aug 14, 2024	SELL	$0.85 - $1.26 $23,375 - $34,650	-27,500 Reduced 50.83%	26,600 $26,000
Q1 2024 May 15, 2024	SELL	$0.91 - $1.75 $23,569 - $45,325	-25,900 Reduced 32.38%	54,100 $69,000
Q4 2023 Feb 14, 2024	BUY	$1.32 - $4.83 $64,548 - $236,187	48,900 Added 157.23%	80,000 $110,000
Q3 2023 Nov 15, 2023	BUY	$3.02 - $4.05 $17,214 - $23,085	5,700 Added 22.44%	31,100 $94,000
Q2 2023 Aug 23, 2023	SELL	$2.79 - $5.03 $837 - $1,509	-300 Reduced 1.17%	25,400 $83,000
Q1 2023 May 15, 2023	SELL	$3.14 - $8.22 $35,168 - $92,064	-11,200 Reduced 30.35%	25,700 $81,000
Q4 2022 Feb 14, 2023	SELL	$5.77 - $8.49 $95,205 - $140,085	-16,500 Reduced 30.9%	36,900 $255,000
Q3 2022 Nov 14, 2022	BUY	$3.75 - $7.39 $200,250 - $394,626	53,400 New	53,400 $304,000
Q4 2021 Feb 14, 2022	SELL	$8.96 - $16.31 $141,568 - $257,697	-15,800 Closed	0 $0
Q3 2021 Nov 12, 2021	SELL	$11.24 - $21.0 $153,988 - $287,700	-13,700 Reduced 46.44%	15,800 $300,000
Q2 2021 Aug 06, 2021	BUY	$18.04 - $22.09 $92,004 - $112,659	5,100 Added 20.9%	29,500 $887,000
Q1 2021 May 14, 2021	SELL	$16.59 - $33.89 $197,421 - $403,291	-11,900 Reduced 32.78%	24,400 $698,000
Q4 2020 Feb 12, 2021	BUY	$27.5 - $37.92 $324,500 - $447,456	11,800 Added 48.16%	36,300 $1.6 Million
Q3 2020 Nov 13, 2020	BUY	$34.44 - $43.75 $61,991 - $78,750	1,800 Added 7.93%	24,500 $1.35 Million
Q2 2020 Aug 13, 2020	SELL	$27.12 - $45.97 $37,968 - $64,358	-1,400 Reduced 5.81%	22,700 $1.36 Million
Q1 2020 May 11, 2020	SELL	$26.16 - $63.5 $585,984 - $1.42 Million	-22,400 Reduced 48.17%	24,100 $1.13 Million
Q4 2019 Feb 12, 2020	BUY	$46.96 - $61.67 $554,128 - $727,706	11,800 Added 34.01%	46,500 $4.07 Million
Q3 2019 Nov 14, 2019	BUY	$59.47 - $93.1 $5,947 - $9,310	100 Added 0.29%	34,700 $3.22 Million
Q2 2019 Aug 20, 2019	BUY	$75.84 - $105.21 $2.62 Million - $3.64 Million	34,600 New	34,600 $4.4 Million
Q4 2018 Feb 14, 2019	SELL	$59.1 - $93.26 $3.67 Million - $5.79 Million	-62,100 Closed	0 $0
Q3 2018 Nov 14, 2018	BUY	$88.86 - $117.49 $1.85 Million - $2.44 Million	20,800 Added 50.36%	62,100 $9.07 Million
Q1 2018 May 15, 2018	BUY	$105.8 - $150.94 $74,060 - $105,658	700 Added 1.72%	41,300 $7.05 Million
Q4 2017 Feb 14, 2018	BUY	$81.25 - $130.7 $292,500 - $470,519	3,600 Added 9.73%	40,600 $7.23 Million
Q3 2017 Nov 15, 2017	BUY	$57.74 - $91.42 $2.14 Million - $3.38 Million	37,000	37,000 $5.08 Million

Others Institutions Holding BLUE

# of Institutions

150

Shares Held

63.4M

Call Options Held

264K

Put Options Held

428K

Black Rock Inc. New York, NY

15.4M
Shares

$131 Million
0.0% of portfolio
Vanguard Group Inc Valley Forge, PA

10.5M
Shares

$89 Million
0.0% of portfolio
Geode Capital Management, LLC Boston, MA

4.68M
Shares

$39.8 Million
0.0% of portfolio
Pictet Asset Management Sa Geneva 73, V8

4.67M
Shares

$39.7 Million
0.02% of portfolio
State Street Corp Boston, MA

3.84M
Shares

$32.7 Million
0.0% of portfolio

View Full List

About bluebird bio, Inc.

Ticker BLUE
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 77,121,800
Market Cap $656M
Description
bluebird bio, Inc., a biotechnology company, researches, develops, and commercializes transformative gene therapies for severe genetic diseases. Its product candidates for severe genetic diseases include betibeglogene autotemcel for the treatment of transfusion-dependent ß-thalassemia; lovotibeglogene autotemcel for the treatment of sickle cell ...

More about BLUE

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Wolverine Trading, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Wolverine Trading, LLC with notifications on news.

Account